HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Masayuki Senda Selected Research
Masayuki Senda Research Topics
Disease
8
Type 2 Diabetes Mellitus (MODY)
02/2021 - 09/2016
7
Diabetes Mellitus
02/2021 - 09/2019
5
Drug-Related Side Effects and Adverse Reactions
02/2021 - 09/2016
3
Hypoglycemia (Reactive Hypoglycemia)
02/2021 - 01/2020
1
Type 1 Diabetes Mellitus (Autoimmune Diabetes)
02/2021
1
Weight Loss (Weight Reduction)
07/2020
1
Urinary Tract Infections (Urinary Tract Infection)
10/2017
1
Body Weight (Weight, Body)
10/2017
Drug/Important Bio-Agent (IBA)
10
6- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triol
IBA
02/2021 - 09/2016
6
Glucose (Dextrose)
FDA Link
Generic
07/2020 - 09/2016
5
Insulin (Novolin)
FDA Link
02/2021 - 10/2017
5
Sodium
IBA
07/2020 - 09/2016
4
Insulin Glargine (Lantus)
FDA Link
02/2021 - 01/2017
2
Glycated Hemoglobin (Glycosylated Hemoglobin)
IBA
02/2021 - 07/2020
2
Symporters
IBA
10/2017 - 09/2016
1
Hypoglycemic Agents (Hypoglycemics)
IBA
03/2020
1
Glucagon-Like Peptide-1 Receptor
IBA
11/2019
1
Solutions
IBA
01/2018
1
Sodium-Glucose Transport Proteins
IBA
11/2017
1
Sodium-Glucose Transporter 2 Inhibitors
IBA
10/2017
1
Uric Acid (Urate)
IBA
10/2017
1
lixisenatide
IBA
01/2017
1
Sitagliptin Phosphate (Januvia)
FDA Link
01/2017
Therapy/Procedure
3
Therapeutics
09/2019 - 10/2017